Oral Semaglutide, A New Option in the Management of Type 2 Diabetes Mellitus: A Narrative Review
figureposted on 2020-09-03, 09:53 authored by Areti Sofogianni, Konstantinos Tziomalos
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.